These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26454490)

  • 1. Neural network models - a novel tool for predicting the efficacy of growth hormone (GH) therapy in children with short stature.
    Smyczynska J; Hilczer M; Smyczynska U; Stawerska R; Tadeusiewicz R; Lewinski A
    Neuro Endocrinol Lett; 2015; 36(4):348-53. PubMed ID: 26454490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
    Hilczer M; Smyczyńska J; Lewiński A
    Neuro Endocrinol Lett; 2006; 27(1-2):149-52. PubMed ID: 16648787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
    Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
    Kriström B; Lundberg E; Jonsson B; Albertsson-Wikland K;
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
    Ben-Ari T; Lebenthal Y; Phillip M; Lazar L
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):101-4. PubMed ID: 25153217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease.
    Nissel R; Lindberg A; Mehls O; Haffner D;
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1359-65. PubMed ID: 18198222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size.
    Hilczer M; Szalecki M; Smyczynska J; Stawerska R; Kaniewska D; Lewinski A
    Neuro Endocrinol Lett; 2005 Oct; 26(5):447-52. PubMed ID: 16264418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
    Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C
    Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Recombinant Growth Hormone Treatment in Children with Idiopathic Short Stature and Low Insulin-Like Growth Factor-1 Levels.
    Şıklar Z; Kocaay P; Çamtosun E; İsakoca M; Hacıhamdioğlu B; Savaş Erdeve Ş; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2015 Dec; 7(4):301-6. PubMed ID: 26777041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.